Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC3337 Mhi-148

Near-infrared cyanine dye, acting as an optical imaging agent

DCC3338 Mhi-i2

Novel photodynamic antitumor agent

DCC3339 mhy1556

Novel tyrosinase inhibitor, showing concentration-dependent inhibitory effects with no significant cytotoxicity in cell viability assay

1446352-58-4
DCC3340 mhy218

Novel potent HDAC inhibitor, possessing potent anticancer activities

1326750-59-7
DCC3341 Mhy219

Novel potent histone deacetylase (HDAC) inhibitor, inducing apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells

1326750-61-1
DCC3342 mhy336

Novel topoisomerase II inhibitor, markedly inducing apoptotic cell death via the mitochondria-mediated intrinsic pathway in LNCaP cells

84858-42-4
DCC3343 mhy384

Novel tyrosinase inhibitor, down-regulating of MITF and tyrosinase through direct tyrosinase inhibition

1367664-23-0
DCC3344 mhy407

Novel sensitizer of cancer cells, significantly increasing DNA damage as determined by DNA breakage, levels of damage-responsive proteins, and DNA foci

1453811-70-5
DCC3345 Mhy-449

Novel inducer of G2/M phase arrest in the cell cycle progression, resulting in growth inhibition and induction of apoptosis in a concentration-dependent manner, and inhibition of proliferation in a time-dependent manner

DCC3346 mhy498

Novel inhibitor of nitric oxide-induced melanogenesis, targeting the NO-induced cGMP signaling pathway

1208535-06-1
DCC3347 mhy-794

Novel tyrosinase inhibitor, directly inhibiting mushroom tyrosinase

1393371-29-3
DCC3348 Mhy884

Novel tyrosinase inhibitor, suppressing UVB-induced activation of NF-κB signaling pathway through the downregulation of oxidative stress

1393371-35-1
DCC3349 Mi-1061

Novel Chemically Stable, Potent, and Efficacious MDM2 Inhibitor

1410737-34-6
DCC3350 Mi-1900

Novel inhibitor of TMPRSS2, also strongly preventing SARS-CoV-2 multiplication and CPE in Calu-3 cells in a dose-dependent manner. causing strong inhibition of SARS-CoV-2 replication

DCC3351 Mi-319

Novel MDM2 antagonist, restoring p53 functions and increases the life span of orally treated follicular lymphoma bearing animals

DCC3352 Mi-432

Novel matriptase-1/matriptase-2 (MT-1/2) inhibitor, also inhibiting TMPRSS2, proteolytic activation and multiplication of influenza A virus in Calu-3 cells

DCC3353 mi-888 Tfa Salt

Highly Potent and Efficacious MDM2 Inhibitor

1303609-30-4
DCC3354 Microtubule Inhibitor 185322

Novel inhibitor of microtubule assembly, inducung mitotic arrest and apoptosis of MM cells

1027308-36-6
DCC3355 Mif Degrader Md13

Novel Potent MIF Degrader

DCC3356 Mifamurtide

Immunomodulator, regulating the activation of monocytes and macrophages, upregulating the secretion of pro-inflammatory cytokines such as TNF-alpha, IL-1, IL-8, nitric oxide and prostaglandins E2 and D2

83461-56-7
DCC3357 Mig-7 Inhibitor D-39

Novel inhibitor of Migration-Inducting Gene 7 (MIG-7) expression, suppressing EOC cell growth and VEGFA expression

DCC3358 Miglustat

Product Description:

72599-27-0
Page 1374 / Total 1558 FirstPrevNextLastGoto